Results 101 to 110 of about 5,029 (156)
TNF-α inhibitors have demonstrated efficacy both as monotherapy and in combination with disease-modifying anti-rheumatic drugs (DMARDs) in the treatment of chronic inflammatory immune-mediated diseases such as rheumatoid arthritis, Crohn's disease ...
PELLECCHIO, MARCO +15 more
core +1 more source
UEG Week 2025 Poster Presentations
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley +1 more source
BackgroundJuvenile Idiopathic Arthritis (JIA) is the most common chronic arthritis in children, causing significant joint inflammation and complications. This study evaluates the incidence, prevalence, and treatment patterns of JIA in Taiwan, focusing on
Ya-Chiao Hu +10 more
doaj +1 more source
NEW OPPORTUNITIES IN TREATMENT OF JUVENILE ANKYLOSING SPONDYLOARTHRITIS
Development of effective and safe methods of treatment of juvenile ankylosing spondyloarthritis is one of topical problems of modern rheumatology. At the same time, the number of antirheumatic drugs used for the treatment of this disease is limited.
E.I. Alexeeva +5 more
openaire +2 more sources
Kaisu M Kotaniemi1, Pirjo M Salomaa1, Kristiina Sihto-Kauppi1, Hanna M Säilä2, Markku J Kauppi31Department of Ophthalmology;2Pediatric Rheumatology;3Rheumatology, Rheumatism Foundation Hospital, Heinola, FinlandObjective: To determine ...
Kaisu M Kotaniemi +4 more
doaj
Sex differences in clinical and imaging characteristics of axial juvenile spondyloarthritis. [PDF]
Mayer AS +4 more
europepmc +1 more source
Advancing Juvenile Spondyloarthritis: Closing Knowledge Gaps with New Axial JSpA Classification Criteria. [PDF]
Newby BN, Weiss PF.
europepmc +1 more source
A rare clinical image of a 16-year-old adolescent with juvenile spondyloarthritis. [PDF]
Brahmane NA, Hullumani S.
europepmc +1 more source
Effect of Characteristic Inflammatory and Structural Pelvic Magnetic Resonance Imaging Lesions on Expert Assessment of Axial Juvenile Spondyloarthritis. [PDF]
Mayer A +28 more
europepmc +1 more source

